Jean-Claude Kaplan

Title: Innovations of Jean-Claude Kaplan in the Field of Adhalinopathy Detection

Introduction

Jean-Claude Kaplan is a notable inventor based in Paris, France. He has made significant contributions to the field of genetics, particularly in the detection of primary adhalinopathy. His work has implications for understanding and diagnosing this rare genetic condition.

Latest Patents

Kaplan holds a patent for "Methods for detecting primary adhalinopathy." This patent discloses compositions and methods for the detection of primary adhalinopathy. Specifically, it includes nucleic acid probes that hybridize specifically, under stringent hybridization conditions, to a mutant adhalin gene or its complement, while not binding to the corresponding region of a wild-type adhalin gene. The patent also outlines methods for detecting mutations in the human adhalin gene responsible for primary adhalinopathy. These methods utilize the nucleic acid probes for detection through hybridization and direct DNA sequencing techniques.

Career Highlights

Jean-Claude Kaplan is associated with the University of Iowa Research Foundation, where he has been able to further his research and innovations. His work has been instrumental in advancing the understanding of genetic disorders.

Collaborations

Kaplan has collaborated with notable colleagues such as Steven L. Roberds and Kevin P. Campbell. Their combined expertise has contributed to the advancements in the detection methods for genetic conditions.

Conclusion

Jean-Claude Kaplan's innovative work in the detection of primary adhalinopathy showcases the importance of genetic research in medical diagnostics. His contributions are vital for the ongoing efforts to understand and treat genetic disorders.